CLL 1st-line I+V, CLL 13-Studie

Activity: Talk or presentation › Contributed talk › science-to-science

Period20 Mar 2019
Event titleJanssen Ad Board
Event typeConference
LocationAustriaShow on map

Fields of science

  • 302 Clinical Medicine
  • 302024 Haematology
  • 302055 Oncology